tiprankstipranks

Gregg Alton Insider Profile

4 Followers
Gregg Alton, Chief Patient Officer at Gilead Sciences, holds 58.05K shares in Gilead Sciences (Ticker: GILD), holds ― shares in Corcept Therapeutics (Ticker: CORT), holds 3.80K shares in Novavax (Ticker: NVAX).
tipranks
Gregg Alton

Gregg Alton
Gilead Sciences (GILD)
Chief Patient Officer

Ranked #18,344 out of 98,501 Corporate Insiders

Profitable Transactions

65%
30 out of 46 Profitable Transactions

Average Return

+2.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
99.62%
0.38%
0.00%
0.00%
0.00% Others
A breakdown of Gregg Alton's holdings

Insider Roles

Gilead Sciences
(GILD)
Chief Patient Officer
Novavax
(NVAX)
Director
Corcept Therapeutics
(CORT)
Director
Renovaro Biosciences
(RENB)
Director
+2 other positions
Roles that Gregg Alton holds in companies

Most Profitable Insider Trade

Stock:
Gilead Sciences
(GILD)
Rating:Informative Sell
Date:Apr 21, 2016 - Apr 21, 2017
Return:+33.50%
The most profitable trade made by Gregg Alton

Gregg Alton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Gilead Sciences
Mar 05, 2019
Chief Patient Officer
Uninformative Buy
18.96K
$3.84M
Corcept Therapeutics
Director
Novavax
Jun 13, 2023
Director
Uninformative Buy
$14.78K
Renovaro Biosciences
Director
Eiger Biopharmaceuticals
Director
$0.00
Sonoma Pharmaceuticals
Director
$0.00
List of latest transactions for each holding click on a transaction to see Gregg Alton's performance on stock

Gregg Alton insider profile FAQ

What is the percentage of profitable transactions made by Gregg Alton?
The percentage of profitable transactions made by Gregg Alton is 65%.
    What is the average return per transaction made by Gregg Alton?
    The average return per transaction made by Gregg Alton is 2.60%.
      What stocks does Gregg Alton hold?
      Gregg Alton holds: GILD, CORT, NVAX, RENB, EIGRQ, SNOA stocks.
        What was Gregg Alton’s latest transaction?
        Gregg Alton latest transaction was an Uninformative Buy of $18.96K.
          What was Gregg Alton's most profitable transaction?
          Gregg Alton’s most profitable transaction was an Informative Sell of GILD stock on April 21, 2016. The return on the trade was 33.50%.
            What is Gregg Alton's role in Gilead Sciences?
            Gregg Alton's role in Gilead Sciences is Chief Patient Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.